Search

everythinglearnresearchcommunity

for

Search:↓

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Topical minoxidil showed promise for early male pattern baldness.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

Pimecrolimus cream is not effective for treating alopecia areata.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Topical tofacitinib is effective and safe for treating alopecia areata.